Canada markets closed

Boule Diagnostics AB (publ) (BDABF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.51000.0000 (0.00%)
At close: 11:59AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
571,329
571,329
548,088
463,344
400,458
Cost of Revenue
321,615
321,615
320,182
264,709
223,273
Gross Profit
249,714
249,714
227,906
198,635
177,185
Operating Expenses
Research Development
53,091
53,091
51,569
43,327
83,098
Selling General and Administrative
153,353
153,353
143,595
120,150
110,935
Total Operating Expenses
206,212
206,212
194,426
162,776
181,639
Operating Income or Loss
43,502
43,502
33,480
35,859
-4,454
Interest Expense
11,264
11,264
9,821
5,448
4,064
Income Before Tax
30,100
30,100
20,849
28,768
-49,021
Income Tax Expense
5,123
5,123
8,121
5,496
-1,056
Income from Continuing Operations
24,977
24,977
12,728
23,272
-47,965
Net Income
24,977
24,977
12,728
23,272
-47,966
Net Income available to common shareholders
24,977
24,977
12,728
23,272
-47,966
Basic EPS
0.52
-
0.46
0.87
-1.75
Diluted EPS
0.52
-
0.45
0.86
-1.75
Basic Average Shares
36,858
-
27,944
26,678
27,420
Diluted Average Shares
36,858
-
28,477
27,211
28,195